AURO-APIXABAN

auro pharma inc🇨🇦 Health Canada

Approval Id: 672e62f6ab79b03c
Drug Approval Canada Name: AURO-APIXABAN
Product Name: AURO-APIXABAN
Status: Marketed
Status Date: 2022-11-28
Original Market Date: 2022-11-28
Din: 02486814
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF02 APIXABAN
Atc Name: b 01 af 02
Aig Number: 0153051002
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

APIXABAN

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

672e62f6ab79b03c

Type

Standard